Search results for the

This data primarily relates to the application of the previous (or legacy) model, which was discontinued at the end of the 2020-21 academic year, and replaced by the new model.

This report provides highlights from the data set produced, focusing on time and quality wherever possible.

Guidance on how employers can support international applicants, and those who have recently registered with the HCPC

Rachael is the Deputy Superintendent Radiographer at St George's University Hospitals in London

This report is the fourth in a series on research relating to the professions registered with the HCPC. It is part of our commitment to building the evidence base of regulation and being innovative in our approach. 

The Health and Care Professions Council response to NHS England’s consultation on the proposal for the supply and administration of medicines using patient group directions for clinical scientists across the United Kingdom. 

The People and Resources Committee 

We ask all applicants applying through the international route to confirm their proficiency with the English language

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

This policy sets out the HCPC’s approach to checking applications for plagiarism as part of the international registration process.

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

Snapshot of outcomes related to the HCPC’s education function for the 2019-20 academic year

We have emphasised the role and importance of leadership at all levels of practice. This is one theme within the key changes to the updated standards of proficiency for all professions.

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Statistical summary of the HCPC Register, including the number of registrants by profession, age profile and working location.